Innovating Works
Mostrando 1 al 20 de 441 resultados
REACTIVA: The transcriptional regulation of cardiomyocyte polyploidization and its relevance in cardiac regeneration CENTRO NACIONAL DE INVESTIGACIONES CARDIOVASCULARES CARLOS III FSP tramitó un HORIZON EUROPE: The mammalian heart is a non-regenerative organ due to the extremely limited ability of fully differentiated cardiomyocytes (CMs) to proliferate. While neonatal hearts still contain mostly diploid CMs...
2024-05-14 | Financiado
ImnovAth: Targeting the Imidazoline I1 receptor as a novel treatment for Atherosclerosis CENTRO NACIONAL DE INVESTIGACIONES CARDIOVASCULARES CARLOS III FSP tramitó un HORIZON EUROPE: Atherosclerosis (AT) is one of the main causes of death worldwide. Current treatments (e.g. lipid-lowering therapies) are still insufficient to tackle future CV events and we urgently need new complem...
2024-03-08 | Financiado
ABCardionostics: Human Antibody-enabled Cardiovascular Personalized Theranosis IMS bordeaux tramitó un HORIZON EUROPE: ABCardionostics envisions an innovative multi-marker-based positron emission tomography (PET)/ magnetic resonance imaging (MRI) system for efficient staging and personalized treatment of vulnerable pa...
2024-02-29 | Financiado
CURE HEARTandBRAIN: CURE HEARTandBRAIN postdoctoral COFUND programme by CNIC CENTRO NACIONAL DE INVESTIGACIONES CARDIOVASCULARES CARLOS III FSP tramitó un HORIZON EUROPE: The CNIC (Spanish Centre for Cardiovascular Research) is a worldwide recognised research centre dedicated to cardiovascular research. CNIC’s mission is to improve cardiovascular health in the society...
2023-09-19 | Financiado
DCM-NEXT: Enabling advances in diagnosis, patient stratification and treatment for dilated cardiomyopathy patients and families. STICHTING VUMC tramitó un HORIZON EUROPE: Dilated Cardiomyopathy (DCM) is a heart muscle disorder characterised by thinning and stretching of the heart ventricles, making it harder for the heart to pump blood (systolic dysfunction). This diso...
2023-06-20 | Financiado
DILEMMA: DecIphering nucLEar Mechanics in diabetes: a Multi-scAle perspective CENTRO NACIONAL DE INVESTIGACIONES CARDIOVASCULARES CARLOS III FSP tramitó un HORIZON EUROPE: DILEMMA will orient fundamental research to fill a gap in diabetes mellitus (DM) biology, by addressing a relevant biomedical problem in a cross-disciplinary manner, with great societal and economic i...
2022-04-28 | Financiado
PLEC2022-009235: Mecanometabolismo de la insuficiencia cardiaca asociada a la edad - CardioAging CENTRO NACIONAL DE INVESTIGACIONES CARDIOVASCULARES CARLOS III FSP tramitó un AEI: El envejecimiento va acompañado de cambios metabólicos que proporcionan el sustrato para la aparición y complicación progresiva de varias patologías, como la obesidad, la diabetes o la hipertensión. L...
2022-01-01 | Financiado
PDC2022-133606-I00: APLICACIONES DIAGNOSTICAS Y TERAPEUTICAS DEL ANTIGENO ALDH4A1 EN ATEROSCLEROSIS CENTRO NACIONAL DE INVESTIGACIONES CARDIOVASCULARES CARLOS III FSP tramitó un AEI: LA ENFERMEDAD CARDIOVASCULAR (ECV) SIGUE SIENDO LA PRINCIPAL CAUSA DE MORTALIDAD EN EL MUNDO, Y LA MAYORIA DE LAS MUERTES POR ECV SE DEBEN A INFARTO DE MIOCARDIO Y ACCIDENTE CEREBROVASCULAR. LA PRINCI...
2022-01-01 | Financiado
MY MITOCOMPLEX: Functional relevance of mitochondrial supercomplex assembly in myeloid cells CENTRO NACIONAL DE INVESTIGACIONES CARDIOVASCULARES CARLOS III FSP tramitó un H2020: The emerging field of immunometabolism has a strong potential to uncover novel targets for the manipulation of immune cell function. Myeloid cells are involved in innate and adaptive immunity and tole...
2021-11-01 | Financiado
STIMULATE: STING signalling modulation via the Electron Transport Chain CENTRO NACIONAL DE INVESTIGACIONES CARDIOVASCULARES CARLOS III FSP tramitó un H2020: The innate immune response to cytosolic dsDNA via the cGAS-STING pathway has been shown to be essential in the response to various viral, bacterial and parasitic infections, in autoimmunity and in can...
2021-07-01 | Financiado
ProtMechanics-Live: Uncovering Protein Mechanics in Physiology and Disease CENTRO NACIONAL DE INVESTIGACIONES CARDIOVASCULARES CARLOS III FSP tramitó un FP7: Protein mechanics is a key contributor to the form and function of biological systems by mechanisms that are just starting to be unraveled. An ensuing hypothesis is that alteration of protein mechanic...
2021-06-01 | Financiado
RESILIENCE: Remote Ischemic Conditioning in Lymphoma Patients Receiving Anthracyclines. CENTRO NACIONAL DE INVESTIGACIONES CARDIOVASCULARES CARLOS III FSP tramitó un H2020: The increasing life expectancy of the population and the development of effective therapies result in a growing population of aged cancer survivors, which frequently have comorbidities for developing...
2021-06-01 | Financiado
RITA-MI 2: Rituximab in patients with acute myocardial infarction: a phase 2 placebo-controlled randomised clinical trial INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE tramitó un H2020: RITA-MI 2 will assess the impact of a novel therapeutic strategy targeting patients’ immune response on the recovery of heart function after myocardial infarction (MI) in a phase 2 clinical trial.Card...
2021-06-01 | Financiado
AngioUnrestUHD: Understanding and modulating vascular arrest with ultra-high definition CENTRO NACIONAL DE INVESTIGACIONES CARDIOVASCULARES CARLOS III FSP tramitó un FP7: Therapeutic modulation of vascular cell proliferation and migration is essential for the effective inhibition of angiogenesis in cancer or its induction in cardiovascular disease. The current view is...
2021-03-01 | Financiado
MAESTRIA: Machine Learning Artificial Intelligence Early Detection Stroke Atrial Fibrillation SORBONNE UNIVERSITE tramitó un H2020: Atrial fibrillation (AF) and stroke are major health care problems in Europe. They are most often the clinical expression of atrial cardiomyopathy, which is under-recognised due to the lack of specifi...
2021-03-01 | Financiado
TED2021-132296B-C54: BIOINFORMATICA PARA LA DIGITALIZACION DE LA LEUCEMIA INFANTIL CENTRO NACIONAL DE INVESTIGACIONES CARDIOVASCULARES CARLOS III FSP tramitó un AEI: A PESAR DE LOS CONOCIMIENTOS SOBRE LA BIOLOGIA DEL CANCER, PRINCIPALMENTE SOBRE LA GENETICA MOLECULAR Y LA BIOLOGIA CELULAR DEL DESARROLLO DE LA NEOPLASIA MALIGNA NEOPLASICA, UNA GRAN CANTIDAD DE ENFE...
2021-01-01 | Financiado
* Datos extraídos de la documentos o webs disponibles en diferentes organismos públicos.